Correlation Between Pharmaceuticals Portfolio and Congress Large

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Portfolio and Congress Large at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Portfolio and Congress Large into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Portfolio Pharmaceuticals and Congress Large Cap, you can compare the effects of market volatilities on Pharmaceuticals Portfolio and Congress Large and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Portfolio with a short position of Congress Large. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Portfolio and Congress Large.

Diversification Opportunities for Pharmaceuticals Portfolio and Congress Large

0.61

Correlation Coefficient

Pharmaceuticals Portfolio  Congress Large

Poor diversification

The 3 months correlation between Pharmaceuticals and Congress is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Portfolio Phar and Congress Large Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Congress Large Cap and Pharmaceuticals Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Portfolio Pharmaceuticals are associated (or correlated) with Congress Large. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Congress Large Cap has no effect on the direction of Pharmaceuticals Portfolio i.e., Pharmaceuticals Portfolio and Congress Large go up and down completely randomly.

Pair Corralation between Pharmaceuticals Portfolio and Congress Large

Assuming the 90 days horizon Pharmaceuticals Portfolio is expected to generate 2.01 times less return on investment than Congress Large. In addition to that, Pharmaceuticals Portfolio is 1.99 times more volatile than Congress Large Cap. It trades about 0.07 of its total potential returns per unit of risk. Congress Large Cap is currently generating about 0.29 per unit of volatility. If you would invest  4,422  in Congress Large Cap on April 29, 2025 and sell it today you would earn a total of  650.00  from holding Congress Large Cap or generate 14.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Portfolio Phar  vs.  Congress Large Cap

Pharmaceuticals Portfolio

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Portfolio Pharmaceuticals are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Portfolio may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Congress Large Cap

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Congress Large Cap are ranked lower than 22 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Congress Large showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmaceuticals Portfolio and Congress Large

The main advantage of trading using opposite Pharmaceuticals Portfolio and Congress Large positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Portfolio position performs unexpectedly, Congress Large can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Congress Large will offset losses from the drop in Congress Large's long position.

The idea behind Pharmaceuticals Portfolio Pharmaceuticals and Congress Large Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.